"Starting from Jan. 1, the pharma giants will offer their obesity drugs Wegovy and Zepbound through Waltz Health, a digital health company focused on helping employers buy affordable medications. Under the offering, employers will procure the injectables by paying upfront, fixed prices without involving rebates and fees, which are usually paid to PBMs as part of traditional drug purchases."  MORE >>